x
Ariana Pharma
[contact-form-7 404 "Not Found"]

Ariana Pharma
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News & more
    • In The News
    • Case study
    • Publications
      • Publications & Conferences
      • Whitepaper & blog
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

Clinical Trials on Alzheimer’s Disease conference (CTAD) 2019, San Diego, USA

Afshar, M., Williams, C., Parmentier, F., Etcheto, A. & Missling, C. U. Gut Microbiota and Response to Blarcamesine (ANAVEX®2-73) in Alzheimer’s Disease Patients : Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis using KEM ® Arti. Clin. Trials Alzheimer’s Dis. Conf. 2019 73 (2019).
Publication
Afshar, M., Williams, C., Sritharan, N., Etcheto, A. & Missling, C. U. Novel analytics framework for augmenting single-arm Phase 2a open label trials with Real-World external control data: Application to the Blarcamesine (ANAVEX®2-73) study in Alzheimer’s disease matched with propensity corrected patients from Alzheimer’s Di. Clin. Trials Alzheimer’s Dis. Conf. 2019 6, 1–44 (2019).
Publication

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2024 All Rights Reserved